Traditional drug-discovery model ripe for reform
Academic researchers set to play much greater role in pharmaceutical development.
The kit may have improved, but the in-house drug discovery model has HULTON–DEUTSCH/CORBIS
changed relatively little.HULTON–DEUTSCH/CORBIS
With drug pipelines running dry and a slew of blockbuster medicines about to lose patent protection, the voices arguing that the traditional drug-development process is too expensive and inefficient to survive are getting louder.
Source and/or read more: http://goo.gl/LW8Fl
Publisher and/or Author and/or Editor:__Andres Agostini ─ @Futuretronium at Twitter! Futuretronium Book at http://3.ly/rECc